Colchicine and Post-COVID-19 Pulmonary Fibrosis

Clinical trial NCT04818489 · UNKNOWN

Trial details

NCT number: NCT04818489
Sponsor: ClinAmygate
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Pulmonary Fibrosis Interstitial

Start date: 2021-03-25
Primary completion: 2021-08-25
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.